IL17A and colorectal cancer: Reports have also indicated that the CXCL17-GPR35 axis can activate the IL-17 signaling pathway, enhancing the viability of colorectal cancer cells, promoting their migration and invasion, and thus increasing resistance to colorectal cancer [54].